TARDBP and amyotrophic lateral sclerosis: TDP-43 has been identified as an inhibitor of cryptic exons (87,88), and recent evidence implicates aberrant inclusion of two different cryptic exons in the genes STMN2 and UNC13A as potential causative mechanisms underlying TDP-43 pathology in ALS (89–92).